Minimize Uncertainty – Make Informed Decisions – Succeed

Cell_Gene_Therapy

Cell and Gene Therapy Video Recap – October 16, 2025

October 16, 2025AAV Gene Therapy,BioPharma and Tech News,CAR T,Regeneron,AskBio,Bristol Myers Squibb,Rocket Pharmaceuticals,Cell and Gene Therapy News,Kresladi,Abeona Therapeutics,ABO-503,RNA-based gene therapy,LAD-IDB-OTO,Orbital Therapeutics

Here’s your biweekly look at the latest breakthroughs in Cell and Gene Therapy.…

by LucidQuest

Cardiovascular

Cardiovascular Today - October 16, 2025

October 16, 2025gene therapy,BioPharma and Tech News,Cardiovascular Disease,Medtronic,Cardiovascular News,Aortic Valve,LVAD,FDA Clearance,Milestone Pharmaceuticals,Methinks AI,AbbottDapagliflozin,EACTS 2025

Get the latest on Cardiovascular this week, including key industry…

by LucidQuest

Rare Disease news

Rare Disease Today - October 16, 2025

October 16, 2025BioPharma and Tech News,Hunter SyndromeRett syndrome,Rare Disease News,Abeona Therapeutics,ABO-503,BioCryst Pharmaceuticals,Astria Therapeutics,RareNet,PANTHERx Rare,Takeda Pharmaceuticals

This week in Rare Disease: the latest clinical updates, industry progress, and…

by LucidQuest

Cell_Gene_Therapy

Cell and Gene Therapy Today - October 16, 2025

October 16, 2025Duchenne Muscular Dystrophy,BioPharma and Tech News,Parkinson's Disease,Regeneron,Krystal Biotech,Rocket Pharmaceuticals,Cell and Gene Therapy News,Kresladi,Abeona TherapeuticsABO-503,RNA-based gene therapy

This week’s Cell and Gene therapy news covers the latest developments, updates,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040

October 16, 2025Oncology,clinical trials,market access,Regulatory,Ovarian Cancer,biopharma,Lucid Diligence Brief,payer access,diligence,venture financingantibody-drug conjugates

Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Verily UCHealth AI collaboration

October 15, 2025digital health,clinical trials,AI in healthcare,real-world evidence,biopharma,Lucid Diligence Brief,payer access,diligence,data platforms,research infrastructurehealth systems

Lucid Diligence Brief: Verily UCHealth AI collaboration Professional audiences…

by Timos Papagatsias

Immunology

Immunology Today: Zenas MS Deal, J&J FDA Approvals (Oct 8–15, 2025)

October 15, 2025upadacitinib,guselkumab,Icotrokinra,SIMPONI,abbvie,TYK2 inhibitor,golimumab,immunology,Immunology News,CSCC,BioPharma and Tech News,Zenas BioPharma,Eli Lilly,InnoCare Pharma,Ulcerative Colitis,orelabrutinib,TREMFYA,IL-17AA/AF inhibitor,BTK Inhibitor,Nilo Therapeutics,Immunology News,neuro-immune circuits,Palisade Bio,Everest Medicines,Regeneron,etrasimod,Libtayo,VELSIPITY,Cemiplimab,Omvoh,Johnson & Johnson,mirikizumabRinvoq,PALI-2108

This week’s immunology news update includes Zenas BioPharma securing global…

by LucidQuest

Neuroscience

Top Neuroscience News: Video summary (Oct 1 –14, 2025)

October 15, 2025Alzheimer’s blood test,BioNxt Solutions,roche,Immunic Therapeutics,BioPharma and Tech News,progressive multiple sclerosis,neuroscience,dementia care,Eli Lilly,Neuroscience news,Theranica,Pier 88 Health,Nerivio,Neuroscience News,Zenas BioPharma,orelabrutinib,Anavex Life SciencesANAVEX 3-71,C2N Diagnostics

This top neuroscience news video summary covers Pier 88 Health &…

by LucidQuest

Women's_Health

Top Women’s Health News: Video summary (Oct 1 – Oct 14, 2025)

October 15, 2025WHO Foundation,MedinCell,Teva,UZEDY,astrazeneca,risperidone LAI,lilly,Women’s Health Fund,novartis,AHA Go Red,roche,breast health survey,BioPharma and Tech News,Biktarvy,Alzheimers,BioNxt,Gilead,cladribine thin-film,TNBC,Elecsys pTau181,Daiichi Sankyo,American Cancer Society,Gates Foundation,QIMR Berghofer,invasive lobular carcinoma,depression geneticsDatopotamab Deruxtecan,Women's Health News

This video summary includes developments across women’s health highlighting FDA…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kailera Therapeutics $600m Series B

October 15, 2025clinical trials,market access,Regulatory,GLP-1,biopharma,Lucid Diligence Brief,payer access,diligence,venture financing,obesity drugsCDMO capacity

Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…

by Timos Papagatsias

Neuroscience

Neuroscience Today: Roche & Lilly Lead in Alzheimer’s (Oct 7 –14, 2025)

October 14, 2025BioNxt Solutions,dementia care,Alzheimer's Disease,Cadenza Bio,bayer,ERβ ligands,BioPharma and Tech News,cladribine,Eli Lilly,Taysha Gene Therapies,BTK Inhibitor,TSHA-102,Biogen,Stoke Therapeutics,Mandos Health,Zorevunersen,adrabetadex,Hesperos,Theranica,WHO Foundation,Nerivio,Roche Diagnostics,Neuroscience News,Elecsys,Zenas BioPharmaorelabrutinib,Alzheimer’s blood test

This neuroscience update highlights major advances in neurology from leading…

by LucidQuest

Obesity Weekly News

Top Obesity News: Video summary (Sept 30 – Oct 14, 2025)

October 14, 2025Combo therapies,EASO guideline,semaglutide,PAHO,pfizer,Bill Gates,BioPharma and Tech News,obesity news,obesity,Tirzepatide,CT-388,Efsubaglutide Alfa,Obesity News,ASC35,Nimacimab,Ildong ID110521156,GLP-1/GIP dual agonistsOnce-monthly incretins,Oral incretins

This top obesity news video summary includes Chugai’s in-licensing of…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.